Japan orders 150 million doses of Novavax COVID vaccine

Young children with cancer face an especially high risk of hearing loss from chemotherapy drug
7 September 2021
The influence of pheromonal signals on memory generated in the hippocampus
7 September 2021

Japan orders 150 million doses of Novavax COVID vaccine

Japan has agreed to buy 150 million doses of Novavax’s coronavirus vaccine, with Japanese firm Takeda expecting to manufacture the formula for distribution early next year, the drugmaker said Tuesday.

Comments are closed.